Items where Author is "Cherla, Avi"

Cherla, Avi, Kyriopoulos, Ilias ORCID: 0000-0002-3932-8228, Pearcy, Pauline, Tsangalidou, Zoi, Hajrulahovic, Haris, Theodorakis, Pavlos, Andersson, Charlotte E., Mehra, Mandeep R. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2024) Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995–2020: a retrospective secondary data analysis. The Lancet Regional Health - Europe, 47. ISSN 2666-7762

Srivastava, Divya ORCID: 0000-0001-5135-3592, Van kessel, Robin, Delgrange, Marine ORCID: 0000-0001-5742-6027, Cherla, Avi, Sood, Harpreet and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2023) A framework for digital health policy: insights from virtual primary care systems across five nations. PLOS Digital Health, 2 (11). e0000382. ISSN 2767-3170

Jenei, Kristina, Raymakers, Adam J.N., Bayle, Arnaud, Berger-Thürmel, Karin, Cherla, Avi, Honda, Kazunori, Jackson, Christopher C.G.A., Karikios, Deme, Trapani, Dario, Berry, Scott and Gyawali, Bishal (2023) Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study. The Lancet Oncology, 24 (6). 624 - 635. ISSN 1470-2045

Cherla, Avi, Davis, Courtney, Mossialos, Elias ORCID: 0000-0001-8664-9297 and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Faster UK drug approvals by relying on other countries. BMJ (Clinical research ed.), 381. p. 739. ISSN 1756-1833

Cherla, Avi, Mossialos, Elias ORCID: 0000-0001-8664-9297, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Kesselheim, Aaron S. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2022) Post-marketing requirements for cancer drugs approved by the European Medicines Agency, 2004-2014. Clinical Pharmacology and Therapeutics, 112 (4). 846 - 852. ISSN 0009-9236

Cherla, Avi, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2021) The coverage in England of US-approved cancer drugs reply: in reply. JAMA Internal Medicine, 181 (9). 1263 - 1264. ISSN 2168-6106

Cherla, Avi, Naci, Huseyin ORCID: 0000-0002-7192-5751, Kesselheim, Aaron S., Gyawali, Bishal and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2021) Assessment of coverage in England of cancer drugs qualifying for US food and drug administration accelerated approval. JAMA Internal Medicine, 181 (4). 490 - 498. ISSN 2168-6106

Cherla, Avi, Renwick, Matthew, Jha, Ashish and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2020) Cost-effectiveness of cancer drugs: comparative analysis of the United States and England. EClinicalMedicine, 29-30. ISSN 2589-5370

Cherla, Avi, Renwick, Matthew, Stefanini, Giulio, Holmes, David R. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2020) Cost-effectiveness of cardiovascular, obesity, and diabetes mellitus drugs: comparative analysis of the United States and England. Journal of the American Heart Association, 9 (21). ISSN 2047-9980

Cherla, Avi, Howard, Natasha and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2020) The Netflix plus model: Can subscription financing improve access to medicines in low- And middle-income countries? Health Economics, Policy and Law. ISSN 1744-1331